BitDouble

BitDouble

ICO Ended
9,364 Views
Bitdouble is the first decentralized 3rd generation blockchain sports betting and casino platform.also you can hold or stake BDBL for daily interest up to 3% Using the smart blockchian technology, Bitdouble coin is one step ahead of other blockchain casinos, having developed the first playable Visa & secured wallet.

International gambling and betting market is presently experiencing amazing growth. The gambling industry grew at aCAGR of 9% in the last seven years, which is 3 times faster than the global GDP.our project is led by a team of managers with extensive experience in the field of gambling, whose main goal is to provide a pleasant and convenient user experience.
4.2
TOTAL SCORE
5.8
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 27 Aug 2018 - 15 Nov 2018
Whitelist/KYC: Whitelist + KYC
Country: Georgia
Token info
Ticker: BDBL
Platform: Bitcoin
Available for sale: 32,300,000 BDBL (85%)
April 2018
Idea.
May 2018
Market Research.
June 2018
Formation of foundersteam Business plan.
July 2018
Start of Platform Development.
August 2018
WhitePaper Landing page. ICO Launch Platform.
November 2018
Staking and Exchange Launch with Partners.
December 2018
Casino Launch.
January 2019
Establishing Representative Office.
Screenshots taken on 28 Nov 2018
Michael Rangena
Founder & CEO
No participating data
George Mitchell
Co-Founder
No participating data
Changsub Rim
Blockchain Technology Expert
No participating data
Tania Rivas
Financial Office
No participating data

Advisors (4)

Mason Liam
IT Marketer
No participating data
Jammy Daniel
Network Designer
No participating data
Adil Albert
Legal Advisor
No participating data
Georgia Allen
Head of Casino Operations
No participating data
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Pre-Sale
NOBAR
Forget fragmented marketplaces! NOBAR is creating the first ever "Unified Crypto Commerce" to provide a holistic solution to the purchasing problem with cryptocurrency and crypto token. Our two robust functions - "Crypto Commerce" and "Shop-App" will facilitate all possible commercial activities.
Active
Tempo
Tempo is a French licensed, Paris-based, European-wide anchor for Stellar blockchain payments. The company offers online, offline and digital backed remittances to nearly 100 destination countries with over 300 physical agent locations. Tempo is creating the easiest, fastest and most secure bridge between cash and crypto.
Upcoming
Fan360
The first sports community for fans, that covers the complete fan experience. Follow your favourite sports star, club or brand and get rewarded for engaging.
Upcoming
Earth Token
The Natural Asset Exchange blockchain platform and Earth Token cryptocurrency initial coin offering (ICO) token sale provides a unique opportunity to truly transform the Natural Capital Asset market, by creating a Natural Asset Marketplace that allows all stakeholders in the climate value chain to participate.
Upcoming
Data Choice
Take control of your personal data. Your data is used virtually every second you are online, to target you with ads. Data Choice will allow you to take control of what you share, what you keep private, control of the ads you see, and reward you for your data being used.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.